Security Snapshot

J P MORGAN EXCHANGE TRADED F - HEALTHCARE LEADE (JDOC) Institutional Ownership

CUSIP: 46654Q765

13F Institutional Holders and Ownership History from Q4 2023 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

6

Shares (Excl. Options)

104,461

Price

$60.23

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-32,556
Value change
-$1,878,204
Number of holders
6
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$60.68
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • JDOC - J P MORGAN EXCHANGE TRADED F - HEALTHCARE LEADE is tracked under CUSIP 46654Q765.
  • 6 institutions reported positions in Q2 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 9 to 6 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $7,505,513 to $6,332,556.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 6 institutions filings for Q2 2026.

Open SEC evidence

Security key

46654Q765

Latest holder period

Q2 2026

13F holders

6

13D/G owners

0

CIK / CUSIP context first

As of 30 Jun 2026, 6 institutional investors reported holding 104,461 shares of J P MORGAN EXCHANGE TRADED F - HEALTHCARE LEADE (JDOC).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
11
Latest
Q2 2026
Rows shown
1-11 of 11
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 104,461 $6,332,556 -$1,878,204 $60.23 6
2026 Q1 137,017 $7,505,513 +$381,194 $55.56 9
2025 Q4 129,858 $7,528,805 -$30,353 $57.85 10
2025 Q3 126,338 $6,634,571 +$325,546 $52.41 7
2025 Q2 115,565 $5,832,782 +$1,372,813 $50.50 5
2025 Q1 88,316 $4,707,729 -$1,654,071 $51.66 2
2024 Q4 121,010 $6,121,933 +$1,455,146 $50.59 3
2024 Q3 91,567 $5,566,413 -$386,539 $60.79 3
2024 Q2 98,143 $5,748,655 -$1,817,828 $58.59 3
2024 Q1 129,169 $7,562,703 -$3,705,852 $58.55 3
2023 Q4 192,464 $10,369,960 +$10,369,960 $53.88 3
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .